Drug Profile
Immethridine
Alternative Names: BP-1-5375; BP-1.5375; Immethridine dioxalateLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Bioprojet
- Class Antiallergics; Antiemetics; Antihistamines; Drug withdrawal therapies; Imidazoles; Pyridines; Small molecules
- Mechanism of Action Histamine H3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Undefined in France (PO, Suspension)
- 11 Oct 2013 Bioprojet plans a phase I/IIa trial in Healthy volunteers in the Netherlands (NCT01965301)
- 31 May 2009 Preclinical trials in Undefined indication in France (PO)